Viking Global Investors LP

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Viking Global Investors LP
CRD #132272
SEC #801-72433
CIK #0001103804
AUM 78.2 B (2026-06-15)
Employees 274 (28% Investors, 0% Brokers)
Phone203-863-5000
Address600 Washington Boulevard
Stamford, CT 06901-6000
Source [IAPD] [EDGAR] [Website] [LinkedIn]
Total AUM ($B)
806448321602010201520212027
In the News
Fri, 24 Jul 2026 Viking Global Investors admits sitting out AI rally was a costly mistake — Crypto Briefing
Fri, 12 Jun 2026 Viking Global Investors Enters Voting Pact at Standard BioTools with 15.0% Stake — TradingView
Mon, 30 Mar 2026 Valstone Welcomes Viking Global Investors as First Institutional Minority Investor — PR Newswire Canada
Sector Form 13F Holdings Value ($B)
Visa Inc 1.9
Taiwan Semiconductor Manufacturing Co Ltd 1.5
Schwab Charles Corp 1.4
Walt Disney Co 1.3
Fortive Corp 1.2
Air Products & Chemicals Inc /DE/ 1.2
McDonalds Corp 1.1
Sherwin Williams Co 1.0
Tesla Motors Inc 0.9
Apple Inc 0.9
View All
Holdings by Sector ($B)
40322416802011201620212027
Type Form D Funds Date Sold AUM
PE Viking Global Opportunities Vintage IV Offshore LP [2026-03-31] 196.7 M
Filed 2025-09-30 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Commission $100,000 · Revenue Decline to Disclose
PE Viking Global Opportunities Vintage IV Onshore LP [2026-03-31] 1.1 B
Filed 2025-09-30 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Commission $2,100,000 · Revenue Decline to Disclose
PE Viking Partners Opportunities Fund LP 2026-03-31 3.5 B
PE Viking Structured Capital Offshore 2 Intermediate LP 2024-03-28 187.1 M
PE Viking Structured Capital Offshore LP [2023-03-31] 170.5 M 115.5 M
Filed 2023-10-06 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose
PE Viking Structured Capital Onshore LP [2023-03-31] 165.0 M 386.7 M
Filed 2023-10-06 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose
PE Viking Structured Capital Sidecar Offshore 2 LP 2023-03-31 140.7 M
PE Viking Structured Capital Sidecar Offshore LP [2023-03-31] 120.0 M 122.7 M
Filed 2023-10-06 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose
PE Viking Structured Capital Sidecar Onshore LP [2023-03-31] 10.0 M 10.1 M
Filed 2023-10-06 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose
PE Viking Global Opportunities Drawdown Offshore LP [2022-03-31] 699.1 M
Filed 2021-09-30 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose
View All
AUM Breakdown Accounts AUM ($B)
By Client Type
(a) Individuals (other than high net worth individuals) 0 0.0
(b) Individuals (high net worth individuals) 0 0.0
(c) Banking or thrift institutions 0 0.0
(d) Investment companies 0 0.0
(e) Business development companies 0 0.0
(f) Pooled investment vehicles 21 78.2
(g) Pension and profit sharing plans 0 0.0
(h) Charitable organizations 0 0.0
(i) State or municipal government entities 0 0.0
(j) Other investment advisers 0 0.0
(k) Insurance companies 0 0.0
(l) Sovereign wealth funds and foreign official institutions 0 0.0
(m) Corporations or other businesses not listed above 0 0.0
(n) Other 0 0.0
Total 21 78.2
By Discretionary
Discretionary 21 78.2
Non-Discretionary 0 0.0
Total 21 78.2
By Non-United States Persons
Non-United States Persons 53.5
United States Persons 24.7
Total 21 78.2
Limited Partners2011 - 2026
Houston Police Officers' Pension System
New York State and Local Retirement System
Form D Directors Role # Filings # Firms 2011 - 2026
Martin Lang Director 161 31
Brian Smith Director 204 6
Seth Lawry Director 17 4
Daniel Sundheim Executive Officer 47 3
Thomas Purcell Executive Officer 21 2
Viking Global Investors LP Promoter 21 2
David Ott Executive Officer 21 2
O Halvorsen Executive Officer 21 2
Rose Shabet Executive Officer 20 2
Viking Global Performance LLC Executive Officer 7 2
View All
EDGAR Form CIK 2011 - 2026
13F-HR [0001103804]
3 [0001103804]
4 [0001103804]
SC 13D [0001103804]
SC 13G [0001103804]
Form 13D/13G Filer Form 13D/13G Subject Filed
Viking Global Investors LP Standard Biotools Inc [2026-06-12]
Viking Global Investors LP Artiva Biotherapeutics Inc [2026-05-18]
Viking Global Investors LP Altimmune Inc [2026-05-01]
Viking Global Investors LP Lennox International Inc [2026-04-22]
Viking Global Investors LP Veradermics Inc [2026-02-12]
Viking Global Investors LP Regal Rexnord Corp [2026-01-13]
Viking Global Investors LP Chewy Inc [2025-12-30]
Viking Global Investors LP Pepgen Inc [2025-10-03]
Viking Global Investors LP Fortive Corp [2025-07-24]
Viking Global Investors LP Primo Brands Corp [2025-06-18]
View All
Firm Profile (Form ADV)
Discretionary AUM$39.9B
ServesInstitutional
Fund TypesHedge Fund, Private Equity
LEIDYNXLZTYODOIILGV2H13
Form 3/4/5 Subject 2011 - 2026
Viking Global Opportunities GP LLC
Viking Global Investors LP
Viking Global Opportunities Illiquid Investments Sub-Master
Viking Global Opportunities Parent GP LLC
Viking Global Opportunities Portfolio GP LLC
Halvorsen Ole Andreas
Shabet Rose Sharon
Inhibrx Biosciences Inc
Ott David C
BridgeBio Pharma LLC
Acuren Corp
APi Group Corp
Viking Global Equities II LP
Viking Global Performance LLC
Viking Global Equities Master Ltd
Inhibrx Inc
Standard Biotools Inc
RayzeBio Inc
Viking Global Opportunities Drawdown Portfolio GP LLC
Viking Global Opportunities Drawdown Aggregator LP
Viking Global Opportunities Drawdown GP LLC
4D Molecular Therapeutics Inc
Roivant Sciences Ltd
Frazier Lifesciences Acquisition Corp
Rallybio Corp
Dragsa 50 LLC
Amylyx Pharmaceuticals Inc
Dragsa 96 LLC
Dragsa 88 LLC
PROCEPT BioRobotics Corp
Ginkgo Bioworks Holdings Inc
FIGS Inc
Viking Long Fund Master Ltd
Adaptive Biotechnologies Corp
Viking Long Fund GP LLC
Zentalis Pharmaceuticals Inc
Arbutus Biopharma Corp
Sio Gene Therapies Inc
Myovant Sciences Ltd
Urovant Sciences Ltd
Sundheim Daniel S
Viking Global Equities LP
First Data Corp
VGE III Portfolio Ltd
Editas Medicine Inc
Purcell Thomas W JR
Wayfair Inc
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Inhibrx Biosciences Inc INBX
Common Stock
2025-10-07 Sell 25,042 $32.25 807,604
Inhibrx Biosciences Inc INBX
Common Stock
2025-10-07 Sell 16,315 $32.25 526,159
Inhibrx Biosciences Inc INBX
Common Stock
2025-10-07 Sell 308,643 $32.25 9,953,737
BridgeBio Pharma LLC BBIO
Common Stock
2025-06-27 Sell 3,500,000 $44.00 154,000,000
BridgeBio Pharma LLC BBIO
Common Stock
2025-01-31 Sell 3,065,616 $34.90 106,989,998
APi Group Corp APG
Common Stock
2024-06-17 Sell 1,912,750 $38.15 72,971,412
APi Group Corp APG
Common Stock
2024-06-17 Sell 39,032 $38.15 1,489,071
APi Group Corp APG
Common Stock
2024-06-17 Sell 39,032 $38.15 1,489,071
APi Group Corp APG
Common Stock
2024-06-17 Sell 1,912,750 $38.15 72,971,412
Inhibrx Inc INBX
Common Stock
2024-05-30 Other 333,333 $30.00 9,999,990
Inhibrx Inc INBX
Common Stock
2024-05-30 Other 6,305,866 $30.00 189,175,980
Inhibrx Inc INBX
Common Stock
2024-05-30 Other 511,627 $30.00 15,348,810
Inhibrx Inc INBX
Warrants (right to buy) · derivative
2024-05-30 Other 1,038,765 $30.00 31,162,950
APi Group Corp APG
Common Stock
2024-03-05 Sell 60,772 $34.25 2,081,441
APi Group Corp APG
Common Stock
2024-03-05 Sell 2,977,845 $34.25 101,991,191
APi Group Corp APG
Common Stock
2024-03-05 Sell 2,977,845 $34.25 101,991,191
APi Group Corp APG
Common Stock
2024-03-05 Sell 60,772 $34.25 2,081,441
APi Group Corp APG
5.5% Series B Perpetual Convertible Preferred Stock · derivative
2024-02-28 Conversion 196,000 $0.00
APi Group Corp APG
Common Stock
2024-02-28 Conversion 8,036,862 $24.60 197,706,805
APi Group Corp APG
Common Stock
2024-02-28 Conversion 164,016 $24.60 4,034,794
showing 20 of 200 most recent transactions
Comparable Firms State AUM
Wellington Alternative Investments LLC
MA 92.2 B
Aegon USA Investment Management LLC
IA 88.8 B
Leonard Green & Partners LP
CA 85.6 B
Clearlake Capital Group LP
CA 83.6 B
Sequoia Capital Operations LLC
CA 82.2 B
Centerbridge Partners LP
NY 79.9 B
Tiger Global Management LLC
NY 78.0 B
Bain Capital Credit LP
MA 76.3 B
BlackRock Capital Investment Advisors LLC
DE 66.9 B
Blue Owl Credit Advisors LLC
NY 64.9 B
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com